"Dr. Pavel Klein, Dr. Jonathan Ross and Dr. Daisy Bui specialize in general neurology conditions and epilepsy"

During the past decade, Mid-Atlantic Epilepsy and Sleep Center conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 18 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 12 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid-Atlantic Epilepsy and Sleep Center" #1 sponsor was "Mid-Atlantic Epilepsy and Sleep Center, LLC" with 8 trials, followed by "SK Life Science, Inc." with 8 trials sponsored, "Marinus Pharmaceuticals" with 5 trials sponsored, "Eisai Inc." with 4 trials sponsored and "Sunovion" with 4 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid-Atlantic Epilepsy and Sleep Center" #1 collaborator was "Bausch Health Americas, Inc." with 2 trials as a collaborator, "Alexander Rotenberg, M.D., Ph.D" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator and "H. Lundbeck A/S" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Mid-Atlantic Epilepsy and Sleep Center" are "Epilepsy" (15 trials), "Lennox Gastaut Syndrome" (5 trials), "Partial Epilepsy" (5 trials), "Seizures" (5 trials) and "Focal Epilepsy" (4 trials). Many other conditions were trialed in "Mid-Atlantic Epilepsy and Sleep Center" in a lesser frequency.

Most popular intervention types in "Mid-Atlantic Epilepsy and Sleep Center" are "Drug" (45 trials) and "Other" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Eslicarbazepine acetate" (3 trials), "Carisbamate" (2 trials), "Cenobamate" (2 trials) and "Ganaxolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mid-Atlantic Epilepsy and Sleep Center" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Mid-Atlantic Epilepsy and Sleep Center". undefined are not yet recruiting, 14 are recruiting, 3 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 27 completed trials in Mid-Atlantic Epilepsy and Sleep Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mid-Atlantic Epilepsy and Sleep Center, 6 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".